Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Her doctor prescribed the cheaper, generic version of the weight-loss drug after her insurer ... to stop making compounded ...

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, or semaglutide, has been approved for the treatment of patients ...

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...

The U.S. Food and Drug Administration (FDA) recently approved Zepbound ... OSA symptoms while also promoting significant weight loss. Zepbound is an injectable prescription medication created ...

The medication also promotes weight loss, with patients losing an average ... options and eligibility for savings programs. The FDA's approval of Zepbound provides a new approach to treatment ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...